Definiens Appoints Professor Dr. Ralf Huss as Chief Medical Officer

28-Feb-2013 - Germany

Definiens announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as Chief Medical Officer (CMO). Professor Huss brings significant expertise in pathology and will play a key role in expanding Definiens’ leading position in image and data analysis for Digital Pathology in Life Sciences into Tissue Diagnostics and Clinical Digital Pathology.

Professor Huss has more than 20 years of training and experience in histopathology and cancer research, and served previously as Global Head of Histopathology and Tissue Biomarker at Roche Diagnostics, where he was involved in identifying new tissue biomarkers to stratify cancer patients as part of a global Personalized Healthcare strategy. Professor Huss also co-founded the biotech company APCETH for which he remains a member of the management team. In addition Professor Huss holds national and international academic appointments at the Ludwig-Maximilians-University Munich (Germany) and the Wake Forest Institute for Regenerative Medicine (USA).

Other news from the department people

More news from our other portals

So close that even
molecules turn red...